REGNRegeneron Pharmaceuticals, Inc.Healthcare
Performance Rankings
| vs. | Rev. QoQ | Rev. YoY | Profit QoQ | Profit YoY |
|---|---|---|---|---|
| S&P 500(502) | #400 | #101 | #360 | #137 |
| Healthcare(59) | #42 | #10 | #46 | #17 |
Quarterly Revenue
Financial
30/06/2025
30/09/2025
31/12/2025
31/03/2026
Revenue
$3.61BOperating Profit
$745MNet Income
$727MAnnual Revenue
Financial
2023
2024
2025
TTM
Revenue
$14.92BOperating Profit
$3.83BNet Income
$4.42B